PDF factsheet
      Z

antiplatelets drug in post stroke for all type of patients, clinical trials results

aspirin versus placebo
Canadian study (CCSG), 1978
aspirin 325 mg/d
versus
placebo
Double blind
Follow-up duration: ND
Swedish study , 1987
aspirin 1,500 mg/d
versus
placebo

Follow-up duration: 2 y
UK-TIA low dose , 1988
aspirin 300 mg/d
versus
placebo

Follow-up duration: 4 y
UK-TIA high dose , 1988
aspirin 1,200 mg/d
versus
placebo

Follow-up duration: 2y
SALT , 1991
aspirin 75 mg/d
versus
placebo

Follow-up duration: 32 mo
Reuther , 1976
aspirin 1,500 mg/d
versus
placebo

Follow-up duration: 2 y
AITA, 1975
aspirin 1,300 mg/d
versus
placebo

Follow-up duration: 1 y
DCS, 1980
aspirin 1,000 mg/d
versus
placebo

Follow-up duration: 25 mo
AICLA, 1981
aspirin 990 mg/d
versus
placebo

Follow-up duration: 3 y
Lindblad , 1991
aspirin 75 mg/d, during 6 months
versus
placebo

Follow-up duration: 6 mo
Danish low-dose, 1986
aspirin 50-100 mg/d (mean 54 mg/d)
versus
placebo

Follow-up duration: 23 mo
ESPS 2 , 1996
aspirin 50 mg/d
versus
placebo

Follow-up duration: 2 y

  Options


in first

in second

  Filter